Etoposide

DNA damage inducible transcript 3 ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35486884 Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study. 2022 Mar 1
2 32112707 Double-Hit and Triple-Hit Follicular Lymphoma. 2020 Apr 15 1
3 24141009 High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma. 2014 Jan 1
4 23750173 Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma. 2013 May 1
5 17579865 Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas. 2008 Apr 1
6 17683387 Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy. 2007 Aug 1
7 16518603 Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma. 2006 Jun 3
8 12815281 cDNA array analysis of alterations in gene expression in the promyelocytic leukemia cell line, HL-60, after apoptosis induction with etoposide. 2003 Aug 2
9 14645667 Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastoma. 2003 Dec 1
10 14653077 [Clinical analysis of 282 patients with non-Hodgkin's lymphoma]. 2003 Jun 2
11 12090052 [Effectiveness of prolonged oral administration of low-dose etoposide in a case of malignant lymphoma in the mesenterium]. 2002 Jun 1
12 11345781 [High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study]. 2001 Mar 1
13 9818704 Crescentic glomerulonephritis developing 3 months after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. 1998 Oct 1
14 9044846 Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide. 1997 Feb 15 2
15 7563607 [Multicentric Castleman's disease with lymphoid interstitial pneumonia died of aggressive course with adult respiratory distress syndrome]. 1995 Aug 1